Home > Financial Ratios > BIOCON
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 12.4810.8513.9019.8526.93

What is the latest EV/Core EBITDA ratio of BIOCON ?

The latest EV/Core EBITDA ratio of BIOCON is 12.48 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.48
Mar202410.85
Mar202313.90
Mar202219.85
Mar202126.93

How is EV/Core EBITDA of BIOCON Trending?

Years EV/Core EBITDA % Change
Mar2025 12.48
15.02
Mar2024 10.85
-21.94
Mar2023 13.9
-29.97
Mar2022 19.85
-26.29
Mar2021 26.93 -

Other Financial Ratios of BIOCON


Compare EV/Core EBITDA ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹49,736.4 Cr 3.4% 9.1% 16.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,452.0 Cr -0.3% 6% -10.5% Stock Analytics
DIVIS LABORATORIES ₹179,089.0 Cr 3.9% 18.6% 14.5% Stock Analytics
CIPLA ₹121,299.0 Cr -5.2% NA 2.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,456.0 Cr -1% -1.2% 8.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,965.9 Cr -6.8% -2.1% -8.4% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

3.4%

9.1%

16.6%

SENSEX

-0.3%

4.5%

5.7%


You may also like the below Video Courses